Answering important clinical questions — such as whether genetic diversity is a risk factor
for aggressive tumor development or how it relates to treatment resistance — requires analyzing samples from many patients with different types of cancer.
Not exact matches
This is especially true
for multifocal prostate cancer, less
aggressive tumors, and cases of prostatitis or prior prostate irradiation, where MRI alone may not give the correct localization and malignancy grade.»
«This research represents a big step forward in understanding why some
tumors are more
aggressive than others and being able to predict rationally which neoantigens will be the most effective at stimulating an immune response,» said Dr. Balachandran, a member of the David M. Rubenstein Center
for Pancreatic Cancer Research at MSK, and corresponding author of the companion study in Nature.
Many biomarkers are available
for estimating
tumor mass, but a possibly more important aspect of a
tumor's pathology is how
aggressive it is and how fast it is growing.
An experimental drug in early development
for aggressive brain
tumors can cross the blood - brain
tumor barrier, kill
tumor cells and block the growth of
tumor blood vessels, according to a study led by researchers at the Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James).
Therefore, researchers are aggressively looking to find new molecular targets
for this
aggressive brain
tumor.
Several studies have supported a role
for cancer stem cells in the
aggressive brain
tumors called glioblastoma, but those studies involved inducing human
tumors to grow in mice, and as such their relevance to cancer in humans has been questioned.
«Study identifies potential treatment target
for pancreatic cancer: Molecular signature found in 30 percent of PDAC
tumors associated with more
aggressive cancer.»
The test also predicts risk
for having an
aggressive tumor, helping doctors and patients make decisions about whether to wait and monitor test levels or pursue immediate biopsy.
«Finding which mechanisms determine why melanoma is so
aggressive is very complex because more than 80,000 mutations have been described
for this
tumor,» says Direna - Alonso Curbelo, the article's first author.
Glioblastoma is the most
aggressive type of
tumor that originates in the brain and with no curative treatments currently available, the average survival time
for patients ranges from 15 to 18 months.
«
Aggressive cancers contain regions where the cancer cells are starved
for oxygen and die off, yet patients with these
tumors generally have the worst outcome.
«Mouse studies hold promise
for a simple treatment
for an
aggressive gastric
tumor.»
In a major breakthrough
for ovarian and uterine cancers, Yale researchers have defined the genetic landscape of rare, highly
aggressive tumors called carcinosarcomas (CSs), pointing the way to possible new treatments.
«Potential pancreatic cancer target challenged: New research finds PDX1 critical
for cancer growth, but blocking it may lead to more
aggressive tumors.»
Last year, Wittrup showed that delivering antibodies and IL - 2, a signaling molecule that helps to boost immune responses, could halt the growth of
aggressive melanoma
tumors in mice
for as long as the treatment was given.
For years, scientists have observed that
tumor cells from certain breast cancer patients with
aggressive forms of the disease contained low levels of mitochondrial DNA.
Findings published in Oncotarget offer new hope
for children with highly
aggressive brain
tumors like atypical teratoid / rhabdoid
tumor (AT / RT) and medulloblastoma.
Improving the understanding of these genetic changes in these diseases, can point to new directions
for diagnosis and treatment, including a way to potentially differentiate
aggressive tumors from those that are not life threatening.
As this variant also appears to be associated with the development of more
aggressive prostate
tumors, a diagnostic test
for the variant may enable doctors to make more informed decisions as to how closely they should monitor those who are at high risk, and how aggressively they should treat the disease once it presents.
For a majority of patients diagnosed with
aggressive, high - grade
tumors with metastases, the five - year survival rate is about 16 percent, though chemotherapy has been associated with an improvement in survival, and new targeted agents are being tested.
Doctors are already using drugs, such as Herceptin, that specifically target malfunctioning genetic pathways in
tumors, but no such therapies are currently available
for certain
aggressive forms of the disease, such as the triple negative subtype.
In the new study, published online March 27, 2018, in Cell Reports, a team led by UCSF's David Raleigh, MD, PhD, found that increased activity of a gene known as FOXM1 appears to be responsible
for the
aggressive growth and frequent recurrence of these
tumors.
These two aspects of
tumor progression (hypoxia and reoxygenation) cooperate to provide growth advantages essential
for the progressive development of
aggressive tumors [21].
In addition to research on rhabdomyosarcoma, the Ignatius laboratory has also generated new syngeneic zebrafish models of
aggressive Malignant Nerve Sheath
Tumors and hemangiosarcomas
for which there are no effective treatments.
In addition, our investigators have used epigenetic biomarkers to: develop screening tests
for cancer; help guide surgeons in removing cancerous
tumors; predict drug resistance; and, pinpoint more
aggressive cancers.
It can make a difference,
for example, if community members know that
tumors may be more
aggressive in certain populations.
The study, led by the SciLifeLab member Marene Landström, might open new possibilities
for early detection of
aggressive prostate
tumors and novel therapeutic strategies.
«This has important implications
for tumor development because certain cells might be more
aggressive than others,» Beck said.
Many women are «triple negative» No one yet knows precisely why, but African - American women are roughly twice as likely as white women to have triple - negative breast cancer — so called because
tumor cells in this particularly
aggressive form of the disease test negative
for estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER - 2).
Chemotherapy may be recommended
for patients with more
aggressive tumors (e.g. higher grade
tumors).
The prognosis
for cats with mammary
tumors is guarded as mammary
tumors tend to be more
aggressive and metastatic in cats.
Regrettably, dogs and cats develop a number of benign and cancerous
tumors that require
aggressive surgery
for a cure or to provide long - term control.
The best outcome
for your cat is to catch a
tumor early and have
aggressive surgery performed.